JOURNAL OF CLINICAL SURGERY ›› 2026, Vol. 34 ›› Issue (4): 470-472.doi: 10.3969/j.issn.1005-6483.20250617

Previous Articles     Next Articles

Comprehensive management of recurrent pituitary adenomas

MA Jinhui,YI Dongye,WANG Ye   

  1. *Department of Tumor Center,Union Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430022,China
  • Received:2025-06-12 Online:2026-06-08 Published:2026-06-08

Abstract: Pituitary adenomas are common tumors of the endocrine system,most of which are benign.However,despite surgical or medical treatment,some patients experience residual or recurrent tumors,inadequate control of tumor growth,or endocrine dysfunction,presenting significant challenges to clinicians.This article reviews the latest advances in the treatment of recurrent pituitary adenomas,including surgical treatment,medical oncology,and radiotherapy.It focuses on radiotherapy,covering radiotherapy methods,adverse reactions and complications after radiotherapy,protection against radiation damage,and future prospects.

Key words: pituitary adenoma, surgical treatment, drug therapy, radiotherapy, precision radiotherapy

[1] XU Shaowei*,JIAN Weihua,CHEN Zhen,FENG Jianhua,CAI Wensong,XU Bo. Notableissues in papillary thyroid carcinoma with ipsilateral lateral neck lymph node metastasis [J]. JOURNAL OF CLINICAL SURGERY, 2026, 34(3): 245-248.
[2] . Opportunities and challenges of neoadjuvant immunotherapy innon-small cell lung cancer [J]. JOURNAL OF CLINICAL SURGERY, 2025, 33(9): 943-947.
[3] ZHAO Xuefeng,LIU Fei,LI Yong. Research progress of new drugs for advanced gastrointestinal stromal tumors in clinical practice [J]. JOURNAL OF CLINICAL SURGERY, 2025, 33(6): 665-668.
[4] LI Xian Miao, Yirixiatijiang·Amier, WU Huan Lei, HU Jia. Current status and development of clinical drug research for prostate cancer [J]. JOURNAL OF CLINICAL SURGERY, 2025, 33(2): 204-207.
[5] LIU Jingli, AI Nian, YANG Juan, ZHANG Hong, WAN Wenqi, LI Jun, QIU Yue. The relationship between peripheral blood circulating tumor DNA and the efficacy and prognosis of neoadjuvant chemoradiotherapy for locally advanced rectal cancer [J]. JOURNAL OF CLINICAL SURGERY, 2025, 33(11): 1198-1202.
[6] JIANG Qiao, HAO Qingzhi, LI Ranran, WANG Ziyan. Analysis of operative effect of popliteal artery occlusion syndrome in 12 cases [J]. JOURNAL OF CLINICAL SURGERY, 2025, 33(10): 1102-1104.
[7] MU Yongliang, BIAN Xuehai. Clinical status and controversy of parathyroid autotransplantation in the surgical management of Secondary Hyperparathyroidism [J]. JOURNAL OF CLINICAL SURGERY, 2024, 32(1): 96-98.
[8] ZHANG Guangmin, QIU Cheng, LI Qingquan, et al. 〗Analysis of influencing factors of cerebrospinal fluid leakage after endoscopic transsphenoidal pituitary adenoma resection [J]. JOURNAL OF CLINICAL SURGERY, 2023, 31(6): 546-549.
[9] HUANG Jun, LIU Zilin, JI Chuang, et al. The clinical efficacy of locking plate combined with steel cable internal fixation for Vancouver type B1 periprosthetic femoral fracture [J]. JOURNAL OF CLINICAL SURGERY, 2023, 31(4): 312-315.
[10] HU Jun, LUO Junfeng, ZHOU Wenbin, et al. Diagnosis and treatment of simultaneous multiple primary colorectal cancer(clinical analysis of 6 cases) [J]. JOURNAL OF CLINICAL SURGERY, 2023, 31(4): 360-363.
[11] LI Zhen, WANG Yiquan, SONG Shuyue, et al. Effect of gamma knife in treating residual tumors after surgery for invasive pituitary adenoma [J]. JOURNAL OF CLINICAL SURGERY, 2023, 31(4): 398-399.
[12] SHEN Haoyuan, HU Chaohua. Top 10 Hotspots for Breast cancer Surgery [J]. JOURNAL OF CLINICAL SURGERY, 2023, 31(1): 97-100.
[13] XU Dingkai, YANG Qiang, JIA Yanfei, et al. Application of enhanced recovery after surgery concept in neuroendoscopy transsphenoidal pituitary adenoma resection [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(5): 437-440.
[14] ZHANG Fengduo, CHEN Xiaodong, WU Zeyu. Study on serum HIF-1 α and IL-6 expression in predicting the recurrence of elderly patients with pituitary adenomas after the treatment of transsphenoidal surgery [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(2): 142-144.
[15] . The “best” surgery for middle and lower thoracic esophageal squamous cell carcinoma [J]. JOURNAL OF CLINICAL SURGERY, 2021, 29(8): 781-783.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!